Neuroderm Ltd Ord Sh (NDRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,860 | -9,565 | 0 | 0 | -86,890 |
| Depreciation Amortization | 40 | 27 | 0 | 0 | 30 |
| Accounts payable and accrued liabilities | 1,015 | 2,524 | 0 | 0 | 0 |
| Other Working Capital | 90 | 2,454 | 0 | 0 | 570 |
| Other Operating Activity | 20,735 | -834 | 0 | 0 | 83,760 |
| Operating Cash Flow | $-7,980 | $-5,394 | $0 | $0 | $-2,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | -117 | 0 | 0 | -7 |
| Other Investing Activity | -50 | -53 | 0 | 0 | 677 |
| Investing Cash Flow | $-160 | $-170 | $0 | $0 | $670 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,230 | 7,819 | 0 | 0 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,200 |
| Financing Cash Flow | $49,230 | $7,819 | $0 | $0 | $3,200 |
| Exchange Rate Effect | -280 | -358 | 0 | 0 | -750 |
| Beginning Cash Position | 2,430 | 2,435 | 0 | 0 | 1,840 |
| End Cash Position | 43,230 | 4,508 | 0 | 0 | 2,430 |
| Net Cash Flow | $40,800 | $2,073 | $0 | $0 | $580 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,980 | -5,394 | 0 | 0 | -2,530 |
| Capital Expenditure | -120 | -120 | 0 | 0 | 0 |
| Free Cash Flow | -8,100 | -5,514 | 0 | 0 | -2,530 |